Back to Search Start Over

Feasibility, acceptability, and preliminary effects of mindfulness training on antenatal blood pressure.

Authors :
Bublitz MH
Salmoirago-Blotcher E
Sanapo L
Ayala N
Mehta N
Bourjeily G
Source :
Journal of psychosomatic research [J Psychosom Res] 2023 Feb; Vol. 165, pp. 111146. Date of Electronic Publication: 2023 Jan 05.
Publication Year :
2023

Abstract

Background: Hypertensive disorders of pregnancy (HDP) are one of the greatest causes of perinatal morbidity and mortality. Mindfulness training (MT) significantly reduces blood pressure in non-pregnant adults, yet MT has not been tested to reduce blood pressure in the prenatal period.<br />Objectives: The objectives of this pilot randomized clinical trial were to test the feasibility, acceptability, and effects of MT on rates of HDP among pregnant participants at risk for HDP. Exploratory analyses examined effects of MT on antenatal blood pressure.<br />Study Design: Participants were randomized to an 8-week phone-delivered MT intervention or usual care. Feasibility was defined by MT completion. Acceptability was defined by participants' satisfaction with the intervention. HDP outcomes were collected by medical chart review. Antenatal blood pressure values were extracted from medical records.<br />Results: Twenty-nine participants were randomized to phone-based MT (N = 15) or usual care (N = 14). 73% participants completed >5 MT sessions, indicating that MT was feasible. One hundred percent of participants indicated they were "satisfied" or "very satisfied" with the intervention, suggesting the intervention was acceptable. Rates of HDP were lower in the MT vs. usual care condition (9% vs. 29%; OR: 0.25, 95% C.I.: 0.02-2.65) although this did not reach statistical significance. Systolic and diastolic blood pressure levels were significantly lower at follow up among those randomized to MT vs. usual care.<br />Conclusions: Results from this pilot trial suggest that prenatal MT is feasible and acceptable and may be a useful adjunctive preventative treatment for HDP among at-risk pregnant patients.<br />Clinicaltrials: gov identifier is NCT03679117.<br />Competing Interests: Declaration of Competing Interest The authors report no conflicts of interest.<br /> (Copyright © 2023 Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1879-1360
Volume :
165
Database :
MEDLINE
Journal :
Journal of psychosomatic research
Publication Type :
Academic Journal
Accession number :
36621212
Full Text :
https://doi.org/10.1016/j.jpsychores.2023.111146